Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02490345 · ClinicalTrials.gov registry record · Phase 1
Gabapentin as Adjunctive Treatment for Postoperative Pain Control
A Phase 1 study, sponsored by Indiana University.
- Completed
- Registry status
- Phase 1
- Development phase
- 13
- Enrollment target
NCT02490345 is a Phase 1 study that has completed, run by Indiana University. The registered enrollment target is 13 participants.
The verdict
NCT02490345, a Phase 1 study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 13 participants
- Enrollment target
Study Summary
The specific aims of this research study are to use 600 mg gabapentin as an adjunctive treatment for acute postoperative pain control in order to reduce postoperative opiate consumption and improve postoperative pain control.
Interventions
- DRUG Placebo
- DRUG gabapentin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2015-10 |
| Est. Completion | 2017-06-29 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02490345
The ClinicalTrials.gov registry entry for NCT02490345 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02490345 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02490345 about?
NCT02490345 is a clinical study titled "Gabapentin as Adjunctive Treatment for Postoperative Pain Control". The specific aims of this research study are to use 600 mg gabapentin as an adjunctive treatment for acute postoperative pain control in order to reduce postoperative opiate consumption and improve postoperative pain control.
What is the current status of trial NCT02490345?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 13 participants. The study started on 2015-10. Estimated completion is 2017-06-29.
What interventions are being tested in trial NCT02490345?
The interventions under investigation include: Placebo (DRUG), gabapentin (DRUG).
Who is sponsoring clinical trial NCT02490345?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.